Biofrontera (BFRI) Cash from Investing Activities Growth (3y) (2024 - 2025)

Biofrontera (BFRI) Cash from Investing Activities Growth (3y) (2024 - 2025) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Cash from Investing Growth (3y) (Qtr)
1	Haleon	43.83 Bn	42.86 Bn	-	-
2	Teva Pharmaceutical Industries	42.87 Bn	39.22 Bn	2.15 Bn	-53.63%
3	Zoetis	31.41 Bn	29.73 Bn	1.05 Bn	-55.36%
4	Takeda Pharmaceutical	28.55 Bn	22.75 Bn	5.10 Bn	34.35%
5	United Therapeutics	22.08 Bn	19.42 Bn	683.80 Mn	33.61%
6	Viatris	18.73 Bn	17.84 Bn	1.46 Bn	15.92%
7	Neurocrine Biosciences	15.44 Bn	15.05 Bn	935.80 Mn	-2.45%
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn	-36.76%
9	Dr Reddys Laboratories	10.11 Bn	9.94 Bn	-	-
10	Biofrontera	18.87 Mn	14.16 Mn	9.59 Mn	-

Download Data